Aethlon Medical Financials - Benzinga

Aethlon Medical Inc

AEMDNASDAQ

Trade with Public

Trade with Public

$6.78

5.35374.13%

al cierre: Sep 17, 5:00 PM EST

$6.42

-0.36-5.31%

After hour: 7:59 PM EST

PRO

¿Por qué se mueve?:Aethlon Medical shares are trading higher after the company announced that ...

Fusiones y adquisiciones: North Immunology, Inc. ("North Immunology"), Nighthawk Merger Sub Corp., a wholly owned subsidiary of Aethlon, and Nighthawk Second Merger Sub, LLC, a wholly owned subsidiary of Aethlon. announced today it will be merged with Aethlon Medical (AEMD) for $346.5M paid in stock

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Comparar Informe de acciones

Aethlon Medical Financials

Aethlon Medical (AEMD) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Nasdaq Jumps 400 Points; US Weekly Jobless Claims Fall

U.S. stocks climbed Thursday, led by Nasdaq’s 1.54% gain, as jobless claims fell to 196,000. AEMD surged 401%, while RETO plunged 84%.

Avi Kapoor

PRO
Aethlon Medical Q1 EPS $(4.02) Misses $(0.79) Estimate; Cash & Equivalents $4.9M

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(4.02) per share which missed the analyst consensus estimate of $(0.79) by 415.38 percent. This is a 90.52 percent increase over losses of $(42.42) per share

Benzinga Newsdesk

PRO
Aethlon Medical Q4 EPS $0.40 Beats $(2.02) Estimate

Aethlon Medical (NASDAQ:AEMD) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $(2.02) by 119.9 percent. This is a 110.81 percent increase over losses of $(3.70) per share from

Benzinga Newsdesk

Earnings Scheduled For June 10, 2026

Benzinga Insights

PRO
Aethlon Medical Q3 EPS $(2.45) Beats $(2.57) Estimate

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(2.45) per share which beat the analyst consensus estimate of $(2.57) by 4.67 percent. This is a 135.58 percent decrease over losses of $(1.04) per share from

Benzinga Newsdesk

Earnings Scheduled For February 12, 2026

Benzinga Insights

© 2026 Benzinga | All Rights Reserved